DD118992A2 - - Google Patents

Info

Publication number
DD118992A2
DD118992A2 DD18537175A DD18537175A DD118992A2 DD 118992 A2 DD118992 A2 DD 118992A2 DD 18537175 A DD18537175 A DD 18537175A DD 18537175 A DD18537175 A DD 18537175A DD 118992 A2 DD118992 A2 DD 118992A2
Authority
DD
German Democratic Republic
Application number
DD18537175A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DD18537175A priority Critical patent/DD118992A2/xx
Publication of DD118992A2 publication Critical patent/DD118992A2/xx

Links

DD18537175A 1975-04-11 1975-04-11 DD118992A2 (en:Method)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD18537175A DD118992A2 (en:Method) 1975-04-11 1975-04-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD18537175A DD118992A2 (en:Method) 1975-04-11 1975-04-11

Publications (1)

Publication Number Publication Date
DD118992A2 true DD118992A2 (en:Method) 1976-04-05

Family

ID=5499891

Family Applications (1)

Application Number Title Priority Date Filing Date
DD18537175A DD118992A2 (en:Method) 1975-04-11 1975-04-11

Country Status (1)

Country Link
DD (1) DD118992A2 (en:Method)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135109A1 (en) * 1983-08-19 1985-03-27 Nissan Chemical Industries Ltd. Antiatherosclerotic agent
US4639444A (en) * 1984-11-30 1987-01-27 Nissan Chemical Industries Ltd. 3,5-dialkyl-4,6-diaryl-tetrahydro-2H-13,5-thiadiazine-2-thione derivative, process for its production and antihyperlipidemic agent containing it

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135109A1 (en) * 1983-08-19 1985-03-27 Nissan Chemical Industries Ltd. Antiatherosclerotic agent
US4624950A (en) * 1983-08-19 1986-11-25 Nissan Chemical Industries Ltd. Method for treating atherosclerosis hyperlipidema, lipid deposition on arterial walls, or raising the ratio of high density lipoprotein cholesterol to total cholesterol in serum
US4639444A (en) * 1984-11-30 1987-01-27 Nissan Chemical Industries Ltd. 3,5-dialkyl-4,6-diaryl-tetrahydro-2H-13,5-thiadiazine-2-thione derivative, process for its production and antihyperlipidemic agent containing it

Similar Documents

Publication Publication Date Title
NO763011L (en:Method)
FR2335808B1 (en:Method)
JPS5198678A (en:Method)
FR2310946B1 (en:Method)
JPS5215810U (en:Method)
JPS51107891U (en:Method)
JPS5249518U (en:Method)
JPS5635754Y2 (en:Method)
JPS5440315B2 (en:Method)
JPS5218213U (en:Method)
JPS5199226U (en:Method)
JPS51124749U (en:Method)
CH591762A5 (en:Method)
CH596840A5 (en:Method)
CH606538A5 (en:Method)
BG20848A1 (en:Method)
BG21547A1 (en:Method)
BG22907A1 (en:Method)
BG23310A1 (en:Method)
CH586353A5 (en:Method)
CH588734A5 (en:Method)
CH590491A5 (en:Method)
CH591067A5 (en:Method)
CH591324A5 (en:Method)
CH604211A5 (en:Method)